Jabra Enhance Select M3 vs Lexie B3

The Jabra Enhance Select M3 is a premium OTC hearing aid priced at $1,995, earning an A grade with a SoundScore of 4.1/5 in our lab testing. This behind-the-ear device delivers strong overall performance, positioning it well above the OTC category average of 3.69/5. In our testing, the Enhance Select M3 demonstrated notable strengths in speech clarity for quiet environments, scoring 3.8/5—a solid result that sits 0.95 points above the category average. Feedback handling proved excellent at 4.6/5, essentially matching the already-high category standard. Music streaming performance also exceeded category norms by 0.87 points, though the absolute score of 2.8/5 remains mixed rather than exceptional. The device shows limitations in challenging listening situations. Speech in noise scored 1.3/5, falling 0.18 points below the category average and representing a low absolute performance level. Own-voice comfort scored 2.7/5—above the category average by 0.18 points but only mixed in absolute terms, which may affect naturalness during conversations. Consumers seeking alternatives may find similar or better sound performance at lower price points from devices like the Sennheiser All Day Clear or Jabra Enhance Pro 20 at Costco. The Enhance Select M3 is best suited for those who prioritize speech clarity in quieter settings and reliable feedback control, but who encounter fewer noisy environments in their daily routines.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.